Speaker illustration

Professor Kenneth McDonald

St Vincent's University Hospital, Dublin (Ireland)

Prof. Ken McDonald developed the St Vincent's/St Michael’s Heart Failure Unit following his return from his sub-speciality training in heart failure at the University of Minnesota, USA. He has overseen the growth of the Unit into an internationally recognised clinical service and translational heart failure research centre. The Unit clinical programme provides specialist heart failure services to in excess of 5,000 patients across the spectrum of heart failure. In addition, Prof McDonald has developed the St Vincent's Screening to Prevent Heart Failure (STOP-HF) Programme in association with St. Vincent's Collaborative General Practice Group. The STOP-HF study is first-of-type, pragmatic, prospective trial which showed that natriuretic peptide-based screening and collaborative care can reduce the combined rate of left ventricular dysfunction and heart failure as well as major adverse cardiac events. Initially a research project, this effort is now an established clinical service man

Biomarkers - Tips and tricks

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session type: Symposium

Thumbnail

Moderated Poster session 2 - Epidemiology

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Chronic Heart Failure

Session type: Moderated Posters

Thumbnail

Best practise for discharge and follow up of patients hospitalised with acute heart failure: role of natriuretic peptides and point-of-care testing

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Prognosis (Syncope)

Session type: Hands-On Tutorials

Thumbnail

How biomarkers support improved Heart Failure management

Event: ESC CONGRESS 2016

Topic: Biomarkers

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk